Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS)

CNY 21.67

(0.18%)

EBITDA Summary of Shanghai Pharmaceuticals Holding Co., Ltd

  • Shanghai Pharmaceuticals Holding Co., Ltd's latest annual EBITDA in 2023 was 11.24 Billion CNY , down -12.07% from previous year.
  • Shanghai Pharmaceuticals Holding Co., Ltd's latest quarterly EBITDA in 2024 Q3 was 2.4 Billion CNY , down -33.32% from previous quarter.
  • Shanghai Pharmaceuticals Holding Co., Ltd reported an annual EBITDA of 12.25 Billion CNY in 2022, up 0.37% from previous year.
  • Shanghai Pharmaceuticals Holding Co., Ltd reported an annual EBITDA of 10.54 Billion CNY in 2021, up 3.24% from previous year.
  • Shanghai Pharmaceuticals Holding Co., Ltd reported a quarterly EBITDA of 2.4 Billion CNY for 2024 Q3, down -33.32% from previous quarter.
  • Shanghai Pharmaceuticals Holding Co., Ltd reported a quarterly EBITDA of 2.99 Billion CNY for 2024 Q1, up 91.84% from previous quarter.

Annual EBITDA Chart of Shanghai Pharmaceuticals Holding Co., Ltd (2023 - 1993)

Historical Annual EBITDA of Shanghai Pharmaceuticals Holding Co., Ltd (2023 - 1993)

Year EBITDA EBITDA Growth
2023 11.24 Billion CNY -12.07%
2022 12.25 Billion CNY 0.37%
2021 10.54 Billion CNY 3.24%
2020 9.93 Billion CNY 7.15%
2019 9.34 Billion CNY 23.04%
2018 6.72 Billion CNY 27.62%
2017 6.42 Billion CNY 5.46%
2016 5.16 Billion CNY 11.69%
2015 4.97 Billion CNY 10.9%
2014 4.61 Billion CNY 20.65%
2013 3.85 Billion CNY 5.57%
2012 3.78 Billion CNY 2.87%
2011 3.72 Billion CNY 39.36%
2010 2.63 Billion CNY 298.47%
2009 2.49 Billion CNY 23.35%
2008 449.78 Million CNY 38.28%
2007 416.54 Million CNY 42.55%
2006 255.22 Million CNY 44.9%
2005 218.89 Million CNY -31.79%
2004 288.47 Million CNY -20.73%
2003 362.42 Million CNY 20.21%
2002 316.34 Million CNY 18.9%
2001 263.51 Million CNY -17.5%
2000 303.23 Million CNY 38.95%
1999 223.99 Million CNY 38.48%
1998 154.48 Million CNY 507.41%
1997 27.59 Million CNY -7.34%
1996 29.78 Million CNY -0.19%
1995 29.83 Million CNY 13.26%
1994 26.34 Million CNY 4.18%
1993 25.28 Million CNY 0.0%

Peer EBITDA Comparison of Shanghai Pharmaceuticals Holding Co., Ltd

Name EBITDA EBITDA Difference
China Meheco Group Co., Ltd. 2.27 Billion CNY -394.608%
Liaoning Cheng Da Co., Ltd. 465.75 Million CNY -2314.423%
Guangxi LiuYao Group Co., Ltd 1.28 Billion CNY -775.136%